Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ikervis in severe dry eye disease with keratitis under adverse controlled environment exposure
2019-000982-19Phase 4Completed
- Sponsor
- IOBA
- Start
- Oct 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cyclosporine in dry eye syndrome (DED), sponsored by IOBA. Started Oct 2019; status: completed.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on 2019-000982-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000982-19.